Age: 55.0
Sex: M
Vaccine: COVID19, FLUX
Symptoms: Urticaria
Clinical narrative: the red area had very dark edges and light interior; Itch was extreme; interfered with sleep; hives develop first on legs then quickly covering entire body. Hives started raised; booster; Other vaccine same date vaccine date 15Nov2021; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 15Nov2021 15:15 (Lot number: ER8734) at the age of 55 years as dose 3 (booster), single for covid-19 immunisation; influenza vaccine (FLU), administered in arm right, administration date 15Nov2021 (Batch/Lot number: unknown) as dose 1, single. Relevant medical history included: "hypothyroidism" (unspecified if ongoing), notes: other medical history: hypothyroidism, vitiligo; "vitiligo" (unspecified if ongoing), notes: other medical history: hypothyroidism, vitiligo. Concomitant medication(s) included: LEVOTHYROXINE; RESTASIS; VIT D [COLECALCIFEROL]. Vaccination history included: Bnt162b2 (prev dose product: COVID 19, prev dose brand: Pfizer, prev dose brand unknown: False, prev dose lot number: Pfizer EW0171, prev dose lot unknown: False, prev dose administration date: 28Apr2021, prev dose administration time: 03:00 PM, prev dose number: 2, prev dose vaccine location: Right arm), administration date: 28Apr2021, when the patient was 54 years old, for Covid-19 immunization; Bnt162b2 (prev dose brand: Pfizer, prev dose brand unknown: False, prev dose lot number: Pfizer FJ1611, prev dose lot unknown: False, prev dose administration date: 07Apr2021, prev dose administration time: 03:00 PM, prev dose number: 1, prev dose vaccine location: Right arm), administration date: 07Apr2021, when the patient was 54 years old, for Covid-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 15Nov2021 15:15, outcome "unknown", described as "booster"; PRODUCT USE ISSUE (non-serious) with onset 15Nov2021, outcome "unknown", described as "Other vaccine same date vaccine date 15Nov2021"; URTICARIA (non-serious) with onset 25Nov2021, outcome "not recovered", described as "hives develop first on legs then quickly covering entire body. Hives started raised"; SKIN DISCOLOURATION (non-serious), outcome "not recovered", described as "the red area had very dark edges and light interior"; PRURITUS (non-serious), outcome "not recovered", described as "Itch was extreme"; INSOMNIA (non-serious), outcome "not recovered", described as "interfered with sleep". The events "hives develop first on legs then quickly covering entire body. hives started raised", "the red area had very dark edges and light interior", "itch was extreme" and "interfered with sleep" were evaluated at the physician office visit. Therapeutic measures were taken as a result of urticaria, skin discolouration, pruritus, insomnia.  Additional information: 10ish days after booster had hives develop. first on legs then quickly covering entire body. Hives started raised then later flattened into red area. In some cases, the red area had very dark edges and light interior. Itch was extreme and interfered with sleep. Hives would persist for days then new ones would form. ae resulted in [Doctor or other healthcare professional office/clinic visit]. no the patient didn't recovered, for ae treatment was received , ae treatment 2 courses of prednisone, OTC antihistamines, no covid prior vaccination . no covid tested post vaccination . no known allergies  Follow-Up : Follow-up attempts are completed. No further information is expected.